Showing 601-610 of 5104 results for "".
Take 5: Strategies for Optimal Outcomes with Dermal Fillers
https://practicaldermatology.com/columns/take-5/take-5-strategies-for-optimal-outcomes-with-dermal-fillers/21949/A dermatologic surgeon's tips for getting the most from dermal fillers and improving patient satisfaction.Lead Psoriasis Patients Along the Path to Clearance
https://practicaldermatology.com/topics/psoriasis/PD0209_01-php/22873/With so many effective therapies now available, dermatologists must be prepared to guide their patients to the right treatment for their specific presentation.Dispelling the #1 Myth of Asset Protection
https://practicaldermatology.com/topics/practice-management/dispelling-the-1-myth-of-asset-protectionalogy/21119/Why you can lose assets in a medical malpractice lawsuitNew Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/22085/Which Probiotic for Which Disease? Part 2
https://practicaldermatology.com/topics/atopic-dermatitis/which-probiotic-for-which-disease-part-2/23596/The conclusion of this 2-part series reviews the research for probiotics in the management of AD, acne, and psoriasis.Mechanisms for Food Allergy Initiation by Skin Pre-disposed to Atopic Dermatitis
https://practicaldermatology.com/issues/may-june-2025/mechanisms-for-food-allergy-initiation-by-skin-pre-disposed-to-atopic-dermatitis/35922/In this research report, we highlight a 2024 study by Gao et al. investigating the mechanisms underlying food allergy initiation in neonates susceptible to atopic dermatitis (AD).The Value of Radiation as an Option for BCC and SCC
https://practicaldermatology.com/issues/may-june-2025/the-value-of-radiation-as-an-option-for-bcc-and-scc/35919/The Skin Cancer Foundation calls Mohs micrographic surgery the gold standard for treating basal cell carcinomas and squamous cell carcinomas.DermWire TV Extra: 3-Year Clinical Data on Lebrikizumab
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-extra-3-year-clinical-data-lebrikizumab/28648/Study author Melinda Gooderham, MSc, MD, FRCPC, discusses the new three-year clinical data presented at the European Academy of Dermatology & Venereology (EADV) Congress on the efficacy and safety of lebrikizumab, which the FDA recently approved on September 13 for adults and adolescents with moWhat’s New for Treating Hyperhidrosis?
https://practicaldermatology.com/conferences/scale-2023/whats-new-for-treating-hyperhidrosis/20208/The treatment of hyperhidrosis has changed a lot over the years. Larry Green, MD, discusses some of the exciting innovations including targeted alkali thermolysis.Hyperpigmentation Treatment Pearls and More
https://practicaldermatology.com/conferences/cosmetic-surgery-forum-2022/hyperpigmentation-treatment-pearls-and-more/20161/Corey Hartman, MD shares his approach to treating periorbital hyperpigmentation in darker skin types, including using fillers to replace volume, give lift, and replace loss of bony structures and fat pads. Dr. Hartman also discusses the benefits of Cynosure’s PicoSure device to correct hyperpigmenta